Cargando…

Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers

SIMPLE SUMMARY: The relationship between schizophrenia and tumors has sparked much interest and controversy. On the one hand, the health of patients with schizophrenia is affected by a variety of risk factors associated with cancer development, such as smoking, alcohol, and drug abuse. On the other...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Kai, Song, Weichen, Liu, Zhe, Lin, Guan Ning, Yu, Shunying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495962/
https://www.ncbi.nlm.nih.gov/pubmed/36138824
http://dx.doi.org/10.3390/biology11091345
_version_ 1784794151419641856
author Yuan, Kai
Song, Weichen
Liu, Zhe
Lin, Guan Ning
Yu, Shunying
author_facet Yuan, Kai
Song, Weichen
Liu, Zhe
Lin, Guan Ning
Yu, Shunying
author_sort Yuan, Kai
collection PubMed
description SIMPLE SUMMARY: The relationship between schizophrenia and tumors has sparked much interest and controversy. On the one hand, the health of patients with schizophrenia is affected by a variety of risk factors associated with cancer development, such as smoking, alcohol, and drug abuse. On the other hand, early investigations have found that patients with schizophrenia have a lower cancer incidence than the overall population. This phenomenon has prompted new theories on the processes underlying the protective effect. To explore the connection between schizophrenia and tumors, we used two-sample Mendelian randomization and GWAS meta-analysis methods on the GWAS summary data to assess potential genetic links between schizophrenia and 13 cancers. It was revealed that schizophrenia may lead to an increased risk of breast, ovarian, and thyroid cancers. Furthermore, the thyroid-stimulating hormone level is impacted by schizophrenia, which may further affect the estrogen and thyroid hormone levels. Meanwhile, based on our results, AS3MT, SFXN2, and PCCB may be potential biomarkers for preventing breast and thyroid cancers in patients diagnosed with schizophrenia. Therefore, we suggest that patients with schizophrenia should pay close attention to early risk warnings for breast, ovarian, and thyroid cancers. ABSTRACT: The causal relationship between cancer and Schizophrenia (SCZ) remains controversial. Some researchers have found that SCZ is a cancer-preventive factor in cohort studies or meta-analyses, whereas others have found the opposite. To understand more about this issue, we used two-sample Mendelian randomization (2SMR) on available GWAS summary results to evaluate potential genetic connections between SCZ and 13 cancers. We discovered that the genetic susceptibility to schizophrenia lead to an increasing risk of breast cancer (odds ratio [OR] per log-odds increase in schizophrenia risk: 1.049, 95% confidence interval [CI]:1.023–1.075; p = 0.00012; FDR = 0.0017), ovarian cancer (OR, 1.326; 95% CI, 1.267–1.387; p = 0.0007; FDR = 0.0045), and thyroid cancer (OR, 1.575; 95% CI, 1.048–2.365; p = 0.0285; FDR = 0.123). Secondly, we performed a meta-analysis based on the GWAS summary statistics of SCZ and the three significant cancers. Next, we associated genetic variants to genes using two gene mapping strategies: (a) positional mapping based on genomic proximity and (b) expression quantitative trait loci (eQTL) mapping based on gene expression linkage across multiple tissues. As a result, we identified 114 shared loci and 437 shared genes in three groups, respectively. Functional enrichment analysis shows that the most enriched biological pathways are related to epigenetic modification. In addition, we noticed that SCZ would affect the level of thyroid-stimulating hormone (OR, 1.095; 95% CI, 1.006–1.191; p = 0.0354; FDR = 0.177), which may further affect the level of estrogen and the risk of the above three cancers. In conclusion, our findings under the 2SMR assumption provide crucial insights into the risk-increasing effect of SCZ on three cancers’ risk. Furthermore, these results may provide insights into understanding the genetic predisposition and underlying biological pathways of comorbid SCZ and cancers.
format Online
Article
Text
id pubmed-9495962
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94959622022-09-23 Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers Yuan, Kai Song, Weichen Liu, Zhe Lin, Guan Ning Yu, Shunying Biology (Basel) Article SIMPLE SUMMARY: The relationship between schizophrenia and tumors has sparked much interest and controversy. On the one hand, the health of patients with schizophrenia is affected by a variety of risk factors associated with cancer development, such as smoking, alcohol, and drug abuse. On the other hand, early investigations have found that patients with schizophrenia have a lower cancer incidence than the overall population. This phenomenon has prompted new theories on the processes underlying the protective effect. To explore the connection between schizophrenia and tumors, we used two-sample Mendelian randomization and GWAS meta-analysis methods on the GWAS summary data to assess potential genetic links between schizophrenia and 13 cancers. It was revealed that schizophrenia may lead to an increased risk of breast, ovarian, and thyroid cancers. Furthermore, the thyroid-stimulating hormone level is impacted by schizophrenia, which may further affect the estrogen and thyroid hormone levels. Meanwhile, based on our results, AS3MT, SFXN2, and PCCB may be potential biomarkers for preventing breast and thyroid cancers in patients diagnosed with schizophrenia. Therefore, we suggest that patients with schizophrenia should pay close attention to early risk warnings for breast, ovarian, and thyroid cancers. ABSTRACT: The causal relationship between cancer and Schizophrenia (SCZ) remains controversial. Some researchers have found that SCZ is a cancer-preventive factor in cohort studies or meta-analyses, whereas others have found the opposite. To understand more about this issue, we used two-sample Mendelian randomization (2SMR) on available GWAS summary results to evaluate potential genetic connections between SCZ and 13 cancers. We discovered that the genetic susceptibility to schizophrenia lead to an increasing risk of breast cancer (odds ratio [OR] per log-odds increase in schizophrenia risk: 1.049, 95% confidence interval [CI]:1.023–1.075; p = 0.00012; FDR = 0.0017), ovarian cancer (OR, 1.326; 95% CI, 1.267–1.387; p = 0.0007; FDR = 0.0045), and thyroid cancer (OR, 1.575; 95% CI, 1.048–2.365; p = 0.0285; FDR = 0.123). Secondly, we performed a meta-analysis based on the GWAS summary statistics of SCZ and the three significant cancers. Next, we associated genetic variants to genes using two gene mapping strategies: (a) positional mapping based on genomic proximity and (b) expression quantitative trait loci (eQTL) mapping based on gene expression linkage across multiple tissues. As a result, we identified 114 shared loci and 437 shared genes in three groups, respectively. Functional enrichment analysis shows that the most enriched biological pathways are related to epigenetic modification. In addition, we noticed that SCZ would affect the level of thyroid-stimulating hormone (OR, 1.095; 95% CI, 1.006–1.191; p = 0.0354; FDR = 0.177), which may further affect the level of estrogen and the risk of the above three cancers. In conclusion, our findings under the 2SMR assumption provide crucial insights into the risk-increasing effect of SCZ on three cancers’ risk. Furthermore, these results may provide insights into understanding the genetic predisposition and underlying biological pathways of comorbid SCZ and cancers. MDPI 2022-09-12 /pmc/articles/PMC9495962/ /pubmed/36138824 http://dx.doi.org/10.3390/biology11091345 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yuan, Kai
Song, Weichen
Liu, Zhe
Lin, Guan Ning
Yu, Shunying
Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
title Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
title_full Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
title_fullStr Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
title_full_unstemmed Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
title_short Mendelian Randomization and GWAS Meta Analysis Revealed the Risk-Increasing Effect of Schizophrenia on Cancers
title_sort mendelian randomization and gwas meta analysis revealed the risk-increasing effect of schizophrenia on cancers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495962/
https://www.ncbi.nlm.nih.gov/pubmed/36138824
http://dx.doi.org/10.3390/biology11091345
work_keys_str_mv AT yuankai mendelianrandomizationandgwasmetaanalysisrevealedtheriskincreasingeffectofschizophreniaoncancers
AT songweichen mendelianrandomizationandgwasmetaanalysisrevealedtheriskincreasingeffectofschizophreniaoncancers
AT liuzhe mendelianrandomizationandgwasmetaanalysisrevealedtheriskincreasingeffectofschizophreniaoncancers
AT linguanning mendelianrandomizationandgwasmetaanalysisrevealedtheriskincreasingeffectofschizophreniaoncancers
AT yushunying mendelianrandomizationandgwasmetaanalysisrevealedtheriskincreasingeffectofschizophreniaoncancers